(Q45986774)

18 December 2017

title

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor (English)

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

13 November 2022

7

Sette A

1 reference

18 December 2017

author name string

M. T. De Magistris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739971

13 November 2022

J. Alexander

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739971

13 November 2022

M. Coggeshall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739971

13 November 2022

A. Altman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739971

13 November 2022

F. C. Gaeta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739971

13 November 2022

H. M. Grey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739971

13 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

18 December 2017

21 February 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1739971

full work available at URL

13 November 2022

https://api.elsevier.com/content/article/PII:0092867492901394?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

https://api.elsevier.com/content/article/PII:0092867492901394?httpAccept=text/plain

13 November 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

13 November 2022

1 reference

18 December 2017

volume

68

1 reference

18 December 2017

issue

4

1 reference

18 December 2017

page(s)

625-634

1 reference

18 December 2017

T cell receptors in murine autoimmune diseases

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Mechanisms influencing the immunodominance of T cell determinants

13 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

In vivo competition between self peptides and foreign antigens in T-cell activation

13 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules

13 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Molecular Events Mediating T Cell Activation

13 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

The interaction between protein-derived immunogenic peptides and Ia.

13 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides

13 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

13 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

The minimal number of class II MHC-antigen complexes needed for T cell activation

13 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand

13 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Specificity pockets for the side chains of peptide antigens in HLA-Aw68

13 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Biologic significance and therapeutic implications of antigen/MHC interactions

13 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Interaction of peptide antigens and class II major histocompatibility complex antigens

13 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

13 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Mechanisms of antigen processing

13 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

13 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition

13 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin

13 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells

13 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Activation-driven programmed cell death and T cell receptor zeta eta expression

13 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein

13 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Free ligand-induced dissociation of MHC-antigen complexes

13 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

T cell activation in the absence of interleukin 2 (IL 2) results in the induction of high-affinity IL 2 receptor unable to transmit a proliferative signal

13 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins

13 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

A cell culture model for T lymphocyte clonal anergy

13 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

MHC-antigen-T cell interactions: an overview

13 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Antigen Recognition and Peptide-Mediated Immunotherapy in Autoimmune Disease

13 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

13 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link

13 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

13 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

T cell recognition as the target for immune intervention in autoimmune disease

13 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

13 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90139-4

13 November 2022

Identifiers

1 reference

18 December 2017

1 reference

18 December 2017